Collegium Pharmaceutical (COLL) Invested Capital (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Invested Capital of $32.6 million for Q1 2026, up 32.81% year-over-year from $24.6 million in Q1 2025, and up 12.5% quarter-over-quarter from $29.0 million in Q4 2025.
Collegium Pharmaceutical (COLL) Invested Capital (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Invested Capital history runs 13 years deep, the most recent figure standing at $32.6 million for Q1 2026.
- In Q1 2026, Invested Capital rose 32.81% year-over-year to $32.6 million; the TTM figure through Mar 2026 stood at $126.2 million (down 62.55% YoY), while the FY2025 annual figure was $29.0 million, down 55.1% from the prior year.
- Invested Capital for Q1 2026 stood at $32.6 million, up from $29.0 million in the prior quarter.
- The five-year high for Invested Capital was $600.0 million in Q3 2022, with the low at $19000.0 in Q3 2025.
- The 5-year median for Invested Capital is $143.8 million (2022), against an average of $161.4 million.
- The sharpest annual moves came in 2024 and 2025: Invested Capital jumped 595.76% in 2024, then slumped 99.97% in 2025.
- Collegium Pharmaceutical's Invested Capital stood at $575.0 million in 2022, then plunged by 68.12% to $183.3 million in 2023, then sank by 64.77% to $64.6 million in 2024, then sank by 55.1% to $29.0 million in 2025, then increased by 12.5% to $32.6 million in 2026.
- Business Quant data shows COLL's Invested Capital at $32.6 million in Q1 2026, $29.0 million in Q4 2025, and $19000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Collegium Pharmaceutical | 887.48 Mn | 738.16 Mn | 110.29 Mn | 55.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.00 Mn |
| Mar 31, 2026 | 32.63 Mn |
| Dec 31, 2025 | 29.00 Mn |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 64.58 Mn |
| Mar 31, 2025 | 24.57 Mn |
| Dec 31, 2024 | 64.58 Mn |
| Sep 30, 2024 | 64.58 Mn |
| Jun 30, 2024 | 183.33 Mn |
| Mar 31, 2024 | 183.33 Mn |
| Dec 31, 2023 | 183.33 Mn |
| Sep 30, 2023 | 183.33 Mn |
| Jun 30, 2023 | 26.35 Mn |
| Mar 31, 2023 | 241.50 Mn |
| Dec 31, 2022 | 575.00 Mn |
| Sep 30, 2022 | 600.00 Mn |
| Jun 30, 2022 | 143.75 Mn |
| Mar 31, 2022 | 143.75 Mn |
| Dec 31, 2021 | 143.75 Mn |
| Sep 30, 2021 | 143.75 Mn |